Results 181 to 190 of about 61,450 (241)

Integrated metabolomic and transcriptomic analysis reveals novel plasma biomarkers and metabolic pathway dysregulation in latent tuberculosis infection. [PDF]

Microbiol Spectr
Liu D, Feng Z, Meng X, Li Y, Zeng Y, Li Y, Yan F, Wang Y.   +7 more
europepmc   +1 more source

Multidisciplinary management of thyroid eye disease (TED) in patients with latent tuberculosis or chronic hepatitis B. [PDF]

Thyroid Res
Vekinis JS, Lee J, Lee V, Aziz A, Jain R, Feeney C, Bravis V.   +6 more
europepmc   +1 more source

Comparative Diagnostic Performance of TST and IGRAs in the Diagnosis of Latent Tuberculosis Infection: A Systematic Review and Diagnostic Meta-Analysis. [PDF]

Diagnostics (Basel)
Sriram S, Abualfaraj T, Alsharif MA, Zalat M, Alawfi SM, Fadlalmola HA, Albadrani M.   +6 more
europepmc   +1 more source

Identification of risk factors for latent tuberculosis infection in Xinjiang using machine learning. [PDF]

BMC Public Health
Wang Y, Luo Z, Wen X, Yuan L, Wu Y, Kamili M, Xiang Y.   +6 more
europepmc   +1 more source

Pan-Immune-Inflammatory value and risk of latent tuberculosis infection. [PDF]

Sci Rep
Ye X, Kang X, Zhang H, Wang W.
europepmc   +1 more source

One-Month Rifapentine-Isoniazid Regimen Versus Six-Month Isoniazid Monotherapy for Latent Tuberculosis: Experience from a Reference Center. [PDF]

Medicina (Kaunas)
Simões JM, Ferreira D, Mourato T, Pais A, Dias A, Torres M, Coelho L.   +6 more
europepmc   +1 more source

Adalimumab Therapy for Crohn's Disease and Axial Spondyloarthritis in Latent Tuberculosis: <i>A bibliometric-systematic literature review</i>. [PDF]

Sultan Qaboos Univ Med J
Shofa NM, Setiyari Mudjari N, Ekawati R, Arianti A, Zahra Mufida A, Widodo B, Sugihartono T.   +6 more
europepmc   +1 more source

Comparison of Tuberculosis Exposure Frequency and Latent Tuberculosis Infection Rates Among Healthcare Workers by Occupational Classification. [PDF]

J Clin Med
Cheon S, Kim SH, Park JH, Lee YJ, Shin JM, Ryu JS, Hong NS, Cho J, Jun CH, Wi YM.   +9 more
europepmc   +1 more source

Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion. [PDF]

Transpl Infect Dis
Simkins J, Viotti JB, Natori Y, Anjan S, Mattiazzi A, Ortigosa-Goggins M, Guerra G, Roth D, Kupin W, Pagan JA, Cabeza F, Ciancio G, Morsi M, Morris MI.   +13 more
europepmc   +1 more source

Study on the safety evaluation of latent tuberculosis treatment in high‑risk groups for tuberculosis development: Study protocol for a multi‑center prospective observational cohort study in Korea (STEP-TB). [PDF]

PLoS One
Hwang Y, Park Y, Kim HW, Jeong SY, Jeong Y, Stagg HR, Kim JS, Min J.   +7 more
europepmc   +1 more source